{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:59:12Z","timestamp":1787507952355,"version":"build-2736575974"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>\n                    Primary aldosteronism (PA) usually accompanies suppressed plasma renin activity (PRA) through a negative feedback mechanism. While some cases of PA with unsuppressed PRA were reported, there have been no studies about the characteristics of PA with unsuppressed PRA; thus, these characteristics were examined herein. Nine patients with unsuppressed PRA and 86 patients with suppressed PRA were examined. All patients underwent segmental adrenal venous sampling (sAVS) and adrenalectomy, and were pathologically confirmed to have cytochrome P450 11B2 (CYP11B2)-positive aldosterone-producing adenoma according to international histopathology consensus criteria. Unsuppressed and suppressed PRA were defined as PRA levels of &gt; 1.0 and \u2264 1.0 ng\/mL\/hr, respectively, in multiple blood samples obtained in the resting position. The unsuppressed PRA group had higher morning cortisol levels (12.6 [8.5, 13.5] vs. 8.5 [7.1, 11.0] \u03bcg\/dL,\n                    <jats:italic>P<\/jats:italic>\n                    = 0.03) and higher cortisol levels after a 1 mg dexamethasone suppression test (DST) (2.2 [1.6, 2.5] vs. 1.3 [1.0, 1.9] \u03bc g\/dL,\n                    <jats:italic>P<\/jats:italic>\n                    = 0.004) than the suppressed PRA group. The unsuppressed PRA group also showed higher aldosterone levels on the non-surgical side during sAVS (\n                    <jats:italic>P<\/jats:italic>\n                    = 0.02 before adrenocorticotropic hormone (ACTH) stimulation,\n                    <jats:italic>P<\/jats:italic>\n                    = 0.002 after ACTH stimulation), a higher intensity of CYP17 expression in the resected adrenal gland (\n                    <jats:italic>P<\/jats:italic>\n                    = 0.02), and a lower clinical complete success rate 1 year after surgery (\n                    <jats:italic>P<\/jats:italic>\n                    = 0.04) compared with those in the suppressed PRA group. These findings suggest that PA should not be ruled out by unsuppressed PRA among patients with hypertension, particularly when their cortisol levels remain unsuppressed in the 1 mg DST. Meanwhile, it should be acknowledged that patients with unsuppressed PRA have higher aldosterone levels on the non-surgical side, and a lower likelihood of postoperative complete clinical success is to be expected.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0267732","type":"journal-article","created":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T15:49:59Z","timestamp":1651160999000},"page":"e0267732","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Characteristics of aldosterone-producing adenomas in patients without plasma renin activity suppression"],"prefix":"10.1371","volume":"17","author":[{"given":"Haremaru","family":"Kubo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5831-3286","authenticated-orcid":true,"given":"Yuya","family":"Tsurutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuto","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Sunouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5226-2227","authenticated-orcid":true,"given":"Yoshitomo","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rei","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Katsuragawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6869-2224","authenticated-orcid":true,"given":"Hiromitsu","family":"Tannai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5929-4670","authenticated-orcid":true,"given":"Yukiko","family":"Shibahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Kakuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seishi","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Omura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Sasano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8271-7368","authenticated-orcid":true,"given":"Tetsuo","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,4,28]]},"reference":[{"issue":"1","key":"pone.0267732.ref001","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study","volume":"173","author":"JM Brown","year":"2020","journal-title":"Ann Intern Med"},{"issue":"9","key":"pone.0267732.ref002","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1507\/endocrj.EJ11-0133","article-title":"Guidelines for the diagnosis and treatment of primary aldosteronism\u2014the Japan Endocrine Society 2009","volume":"58","author":"T Nishikawa","year":"2011","journal-title":"Endocr J"},{"issue":"5","key":"pone.0267732.ref003","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline","volume":"101","author":"JW Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"pone.0267732.ref004","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1055\/s-0032-1301902","article-title":"Predictive factors of left ventricular mass changes after treatment of primary aldosteronism","volume":"44","author":"C Catena","year":"2012","journal-title":"Horm Metab Res"},{"issue":"2","key":"pone.0267732.ref005","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1507\/endocrj.EJ15-0398","article-title":"Extraordinarily high aldosterone, 901.0 ng\/dL, in a patient with primary aldosteronism: an insight into the underlying mechanism","volume":"63","author":"Y Okubo","year":"2016","journal-title":"Endocr J"},{"issue":"6","key":"pone.0267732.ref006","doi-asserted-by":"crossref","first-page":"138","DOI":"10.2169\/naika.90.1082","article-title":"Primary aldosteronism with renovascular hypertension","volume":"90","author":"M Ogihara","year":"2001","journal-title":"J Jpn Soc Int Med"},{"issue":"9","key":"pone.0267732.ref007","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jcem.85.9.6819","article-title":"Primary hyperaldosteronism without suppressed renin due to secondary hypertensive kidney damage","volume":"85","author":"W Oelkers","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"pone.0267732.ref008","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/HYPERTENSIONAHA.119.14341","article-title":"Precise Mapping of Intra-Adrenal Aldosterone Activities Provides a Novel Surgical Strategy for Primary Aldosteronism","volume":"76","author":"T Kitamoto","year":"2020","journal-title":"Hypertension"},{"issue":"11","key":"pone.0267732.ref009","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1291\/hypres.29.883","article-title":"Clinical characteristics of aldosterone-producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism","volume":"29","author":"M Omura","year":"2006","journal-title":"Hypertens Res"},{"issue":"3","key":"pone.0267732.ref010","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1053\/meta.2002.30498","article-title":"Unique cases of unilateral hyperaldosteronemia due to multiple adrenocortical micronodules, which can only be detected by selective adrenal venous sampling","volume":"51","author":"M Omura","year":"2002","journal-title":"Metabolism"},{"issue":"11","key":"pone.0267732.ref011","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1210\/jc.2016-1963","article-title":"Dietary Sodium Restriction Increases the Risk of Misinterpreting Mild Cases of Primary Aldosteronism","volume":"101","author":"R Baudrand","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"pone.0267732.ref012","article-title":"Low Quality of Reports on Blood Pressure in Patients Adrenalectomized for Unilateral Primary Aldosteronism","volume":"105","author":"JWM Lenders","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"pone.0267732.ref013","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","article-title":"The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)","volume":"42","author":"S Umemura","year":"2019","journal-title":"Hypertens Res"},{"issue":"3","key":"pone.0267732.ref014","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1507\/endocrj.EJ18-0445","article-title":"Changes in glucose metabolism based on 75-g oral glucose tolerance tests before and after surgery for adrenal Cushing\u2019s syndrome","volume":"66","author":"Y Tsurutani","year":"2019","journal-title":"Endocr J"},{"issue":"2","key":"pone.0267732.ref015","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/jdi.13332","article-title":"Impact of primary aldosteronism on renal function in patients with type 2 diabetes","volume":"12","author":"S Katsuragawa","year":"2021","journal-title":"J Diabetes Investig"},{"issue":"5","key":"pone.0267732.ref016","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1161\/HYPERTENSIONAHA.114.04453","article-title":"Measurement of peripheral plasma 18-oxocortisol can discriminate unilateral adenoma from bilateral diseases in patients with primary aldosteronism","volume":"65","author":"F Satoh","year":"2015","journal-title":"Hypertension"},{"issue":"2","key":"pone.0267732.ref017","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1530\/EJE-18-0704","article-title":"MANAGEMENT OF ENDOCRINE DISEASE: The role of confirmatory tests in the diagnosis of primary aldosteronism","volume":"180","author":"J Morera","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"pone.0267732.ref018","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1210\/jc.2015-3284","article-title":"Clinical and Steroidogenic Characteristics of Aldosterone-Producing Adenomas With ATPase or CACNA1D Gene Mutations","volume":"101","author":"T Kitamoto","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"pone.0267732.ref019","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1245\/s10434-011-2121-5","article-title":"What is the best criterion for the interpretation of adrenal vein sample results in patients with primary hyperaldosteronism?","volume":"19","author":"R Webb","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"pone.0267732.ref020","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00000478-198403000-00001","article-title":"Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors","volume":"8","author":"LM Weiss","year":"1984","journal-title":"Am J Surg Pathol"},{"issue":"1\u20132","key":"pone.0267732.ref021","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.mce.2014.05.002","article-title":"Adrenal CYP11B1\/2 expression in primary aldosteronism: immunohistochemical analysis using novel monoclonal antibodies","volume":"392","author":"Y Nakamura","year":"2014","journal-title":"Mol Cell Endocrinol"},{"issue":"9","key":"pone.0267732.ref022","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1210\/jc.2018-00738","article-title":"Aldosterone Suppression by Dexamethasone in Patients With KCNJ5-Mutated Aldosterone-Producing Adenoma","volume":"103","author":"K Inoue","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"pone.0267732.ref023","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1055\/s-0043-119878","article-title":"Evaluation of Cortisol Production in Aldosterone-Producing Adenoma","volume":"49","author":"K Inoue","year":"2017","journal-title":"Horm Metab Res"},{"issue":"1\u20132","key":"pone.0267732.ref024","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.mce.2013.11.022","article-title":"Development of monoclonal antibodies against human CYP11B1 and CYP11B2","volume":"383","author":"CE Gomez-Sanchez","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"pone.0267732.ref025","article-title":"International histopathology consensus for unilateral primary aldosteronism","author":"TA Williams","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"pone.0267732.ref026","first-page":"5419","article-title":"Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody","volume":"46","author":"DA Budwit-Novotny","year":"1986","journal-title":"Cancer Res"},{"issue":"9","key":"pone.0267732.ref027","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"TA Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"pone.0267732.ref028","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/01.hjh.0000217857.20241.0f","article-title":"Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol","volume":"24","author":"G Giacchetti","year":"2006","journal-title":"J Hypertens"},{"issue":"4","key":"pone.0267732.ref029","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1507\/endocrj.EJ17-0456","article-title":"New diagnostic criteria of adrenal subclinical Cushing\u2019s syndrome: opinion from the Japan Endocrine Society","volume":"65","author":"T Yanase","year":"2018","journal-title":"Endocr J"},{"issue":"9","key":"pone.0267732.ref030","doi-asserted-by":"crossref","first-page":"630","DOI":"10.7326\/M17-0882","article-title":"The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension: A Cohort Study","volume":"167","author":"JM Brown","year":"2017","journal-title":"Ann Intern Med"},{"key":"pone.0267732.ref031","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fendo.2016.00040","article-title":"The Potential of ACTH in the Genesis of Primary Aldosteronism","volume":"7","author":"JW Funder","year":"2016","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"pone.0267732.ref032","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18050948","article-title":"Clinical Utility of the Adrenocorticotropin Stimulation Test with\/without Dexamethasone Suppression for Definitive and Subtype Diagnosis of Primary Aldosteronism","volume":"18","author":"K Inoue","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"4","key":"pone.0267732.ref033","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1530\/EJE-10-1070","article-title":"Aldosterone- and cortisol-co-secreting adrenal tumors: the lost subtype of primary aldosteronism","volume":"164","author":"M Sp\u00e4th","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"pone.0267732.ref034","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1507\/endocrj.K10E-402","article-title":"Clinicopathological features of primary aldosteronism associated with subclinical Cushing\u2019s syndrome","volume":"58","author":"K Hiraishi","year":"2011","journal-title":"Endocr J"},{"issue":"6","key":"pone.0267732.ref035","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1365-2265.2009.03551.x","article-title":"High prevalence of autonomous cortisol and aldosterone secretion from adrenal adenomas","volume":"71","author":"GP Piaditis","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"pone.0267732.ref036","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1210\/jc.2009-2010","article-title":"Adrenocortical zonation in humans under normal and pathological conditions","volume":"95","author":"K Nishimoto","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"pone.0267732.ref037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1291\/hypres.19.1","article-title":"Mechanism of glucocorticoid-induced hypertension","volume":"19","author":"T. Saruta","year":"1996","journal-title":"Hypertens Res"},{"issue":"2","key":"pone.0267732.ref038","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1210\/jcem-62-2-275","article-title":"Multiple factors contribute to the pathogenesis of hypertension in Cushing\u2019s syndrome","volume":"62","author":"T Saruta","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"pone.0267732.ref039","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000173950","article-title":"Pathogenetic aspects of hypertension in Cushing\u2019s syndrome","volume":"72","author":"W Tenschert","year":"1985","journal-title":"Cardiology"},{"issue":"1","key":"pone.0267732.ref040","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12902-019-0395-y","article-title":"Hypercortisolism and primary aldosteronism caused by bilateral adrenocortical adenomas: a case report","volume":"19","author":"K Ren","year":"2019","journal-title":"BMC Endocr Disord"},{"issue":"5","key":"pone.0267732.ref041","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1507\/endocrj.K06-088","article-title":"A case of preclinical Cushing\u2019s syndrome associated with diurnal rhythms of ACTH and cortisol in blood: correlation with histological findings","volume":"53","author":"T Ikarashi","year":"2006","journal-title":"Endocr J"},{"issue":"4","key":"pone.0267732.ref042","doi-asserted-by":"crossref","first-page":"843","DOI":"10.2337\/dc19-1902","article-title":"Coronary Artery Disease and Type 2 Diabetes: A Proteomic Study","volume":"43","author":"G Ferrannini","year":"2020","journal-title":"Diabetes Care"},{"issue":"5","key":"pone.0267732.ref043","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1055\/s-0032-1331256","article-title":"Aberrant activation of the intrarenal renin-angiotensin system in the developing kidneys of type 2 diabetic rats","volume":"45","author":"YY Fan","year":"2013","journal-title":"Horm Metab Res"},{"issue":"5","key":"pone.0267732.ref044","doi-asserted-by":"crossref","first-page":"938","DOI":"10.2337\/dc18-1293","article-title":"High Prevalence of Diabetes in Patients With Primary Aldosteronism (PA) Associated With Subclinical Hypercortisolism and Prediabetes More Prevalent in Bilateral Than Unilateral PA: A Large, Multicenter Cohort Study in Japan","volume":"42","author":"Y Akehi","year":"2019","journal-title":"Diabetes Care"},{"issue":"5","key":"pone.0267732.ref045","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0002-9149(73)80056-6","article-title":"Relation of age, diastolic pressure and known duration of hypertension to presence of low renin essential hypertension","volume":"32","author":"ML Tuck","year":"1973","journal-title":"Am J Cardiol"},{"key":"pone.0267732.ref046","first-page":"2639813","article-title":"The Association between eGFR and the Aldosterone-to-Renin Ratio and Its Effect on Screening for Primary Aldosteronism","volume":"2020","author":"J Xu","year":"2020","journal-title":"Int J Endocrinol"},{"key":"pone.0267732.ref047","doi-asserted-by":"crossref","first-page":"100750","DOI":"10.1016\/j.eclinm.2021.100750","article-title":"Influence of sodium intake and change in sodium intake on plasma-renin in man","volume":"33","author":"N Graudal","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"8","key":"pone.0267732.ref048","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1291\/hypres.31.1669","article-title":"A case of primary aldosteronism associated with renal artery stenosis and preclinical Cushing\u2019s syndrome","volume":"31","author":"K Tsunoda","year":"2008","journal-title":"Hypertens Res"},{"issue":"11","key":"pone.0267732.ref049","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline","volume":"158","author":"Members KDIGOCKDGDWG","year":"2013","journal-title":"Ann Intern Med"},{"issue":"3","key":"pone.0267732.ref050","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1124\/pr.59.3.3","article-title":"The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease","volume":"59","author":"H Kobori","year":"2007","journal-title":"Pharmacol Rev"},{"issue":"4","key":"pone.0267732.ref051","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1210\/jc.2012-3726","article-title":"Histopathological diagnosis of primary aldosteronism using CYP11B2 immunohistochemistry","volume":"98","author":"K Nanba","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"pone.0267732.ref052","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/0002-9343(65)90122-1","article-title":"Conn\u2019s syndrome due to adrenal hyperplasia with hypertrophy of zona glomerulosa, relieved by unilateral adrenalectomy","volume":"39","author":"EJ Ross","year":"1965","journal-title":"Am J Med"},{"issue":"3","key":"pone.0267732.ref053","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1161\/HYPERTENSIONAHA.118.11465","article-title":"Immunohistopathology and Steroid Profiles Associated With Biochemical Outcomes After Adrenalectomy for Unilateral Primary Aldosteronism","volume":"72","author":"LS Meyer","year":"2018","journal-title":"Hypertension"},{"key":"pone.0267732.ref054","article-title":"The Primary Aldosteronism Surgical Outcome Score for the Prediction of Clinical Outcomes After Adrenalectomy for Unilateral Primary Aldosteronism","author":"J Burrello","year":"2019","journal-title":"Ann Surg"},{"issue":"6","key":"pone.0267732.ref055","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1210\/jc.2002-021476","article-title":"Variability in the renin\/aldosterone profile under random and standardized sampling conditions in primary aldosteronism","volume":"88","author":"A Tanabe","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"pone.0267732.ref056","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/sleep\/32.12.1589","article-title":"Obstructive sleep apnea and aldosterone","volume":"32","author":"A Svatikova","year":"2009","journal-title":"Sleep"},{"issue":"6","key":"pone.0267732.ref057","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/cen.14573","article-title":"Changes in cortisol levels by continuous positive airway pressure in patients with obstructive sleep apnoea: Meta-analysis of 637 individuals","volume":"95","author":"G Ken-Dror","year":"2021","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0267732","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T15:50:59Z","timestamp":1651161059000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0267732"}},"subtitle":[],"editor":[{"given":"Ali S.","family":"Alzahrani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,4,28]]},"references-count":57,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0267732","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,28]]}}}